Atlas Trials

Italfarmaco

35 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Italfarmaco

RecordFirmDate
Pharmacokinetics, Safety and Tolerability of ITF2357 in Participants With Chronic Hepatic Impairment and With Normal Hepatic Function (NCT06736223)Italfarmaco2025-05-29
Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old (NCT06769633)Italfarmaco2025-01-02
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera (NCT06093672)Italfarmaco2024-03-26
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy (NCT05933057)Italfarmaco2024-02-19
A Multicentre, Prospective, Open-label, Non-comparative Study (NCT06067256)Italfarmaco2023-07-20
Multicenter Prospective Real-world Observational Study to Evaluate the Effectiveness of Phlebotonics, as Conservative Therapy in a Cohort of Patients With Symptomatic Hemorrhoidal Disease (HD) of I, II or III Goligher Grade (NCT07376928)Italfarmaco2023-04-05
Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity (NCT05492318)Italfarmaco2022-03-21
Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3) (NCT05860114)Italfarmaco2022-03-21
The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2) (NCT05845567)Italfarmaco2022-03-21
Prevalence And Burden Of Nausea And Vomiting In Pregnant Women (NCT04926727)Italfarmaco2021-10-04
Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval (NCT04821063)Italfarmaco2021-04-13
Open Non-Comparative Clinical Trial Study To Evaluate The Performance And Safety Of Ainara® (NCT04245358)Italfarmaco2019-09-20
Post Marketing Follow Up Study To Evaluate Performance Safety Quality of Menopausal Transition Women Treated With Ainara (NCT04362371)Italfarmaco2019-06-27
Clinical Trial Study To Evaluate The Performance And Safety Of Ainara® (NCT04245293)Italfarmaco2019-04-11
Open Non-Comparative Study To Evaluate Administration Of a New Nutraceutical (NCT04245761)Italfarmaco2018-12-27
Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy (NCT03238235)Italfarmaco2018-01-09
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study (NCT03373968)Italfarmaco2017-10-24

Track Italfarmaco automatically

Every clearance here is in the API, with alerts when new ones post.